Physician profile
Christopher Sonnier
NPI 1598732513
$899.87
in general payments reported to CMS, 2019-2025
18 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2021: $130 · 2022: $260 · 2023: $145 · 2024: $32.88 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $146.71 | 2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $124.80 | 2022 | |
| Ardelyx, INC. | $123.50 | 2023 | Ibsrela |
| Novo Nordisk INC | $116.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $114.71 | 2019 | |
| Medtronic, INC. | $50.57 | 2022 | |
| Dexcom, INC. | $28.10 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.38 | 2022 | |
| Baxter Healthcare | $21.83 | 2023 | Hillrom - Life 2000 Ventilation System |
| Tandem Diabetes Care, INC. | $21.14 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $19.26 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $18.59 | 2024 | Iqirvo |
| Galderma Laboratories, L.P. | $18.44 | 2025 | Nemluvio |
| Sequel Med Tech, LLC | $16.61 | 2025 | Twiist |
| Amgen INC. | $14.29 | 2024 | Tepezza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $14.19 | 2019 | |
| Clarus Therapeutics INC. | $14.04 | 2021 | |
| Abbvie INC. | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sonnier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.